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Alterations in Neural Crest Migration by a Monoclonal 
Antibody that Affects Cell Adhesion 
MARIANNE BRONNER-FRASER 
Department of Physiology and Biophysics, University of California, Irvine, Irvine, California 92717 
ABSTRACT The possible role of a 140-kD cell surface complex in neural crest adhesion and 
migration was examined using a monoclonal antibody JG22, first described by Greve and 
Gottlieb (1982, J. Cell. Biochem. 18:221-229). The addition of JG22 to neural crest cells in 
vitro caused a rapid change in morphology of cells plated on either fibronectin or laminin 
substrates. The cells became round and phase bright, often detaching from the dish or forming 
aggregates of rounded cells. Other tissues such as somites, notochords, and neural tubes were 
unaffected by the antibody in vitro even though the JG22 antigen is detectable in embryonic 
tissue sections on the surface of the myotome, neural tube, and notochord. The effects of the 
JG22 on neural crest migration in vivo were examined by a new perturbation approach in 
which both the antibody and the hydridoma cells were microinjected onto neural crest 
pathways. Hybridoma cells were labeled with a fluorescent cell marker that is nondeleterious 
and that is preserved after fixation and tissue sectioning. The JG22 antibody and hybridoma 
cells caused a marked reduction in cranial neural crest migration, a build-up of neural crest 
cells within the lumen of the neural tube, and some migration along aberrant pathways. Neural 
crest migration in the trunk was affected to a much lesser extent. In both cranial and trunk 
regions, a cell free zone of one or more cell diameters was generally observed between neural 
crest cells and the JG22 hybridoma cells. Two other monoclonal antibodies, 1-B and 1-N, 
were used as controls. Both 1-B and 1-N bind to bands of the 140-kD complex precipitated 
by JG22. Neither control antibody affected neural crest adhesion in vitro or neural crest 
migration in situ. This suggests that the observed alterations in neural crest migration are due 
to a functional block of the 140-kD complex. 
Several important developmental events are accompanied by 
temporal or spatial changes in the composition of the extra-
cellular matrix (ECM). 1 For example, hyaluronate accumu-
lates in the corneal stroma during the invasion of the corneal 
fibroblast and is subsequently removed by increased produc-
tion of hyaluronidase (25). Fibronectin has been implicated 
in guiding cell movement during gastrulation (I) and neural 
crest migration (10, 24) because it lines pathways followed by 
migrating cells. Such correlations have led to the proposal 
that adhesive interactions between the extracellular matrix 
and the embryonic cell surface may play an important role in 
morphogenesis ( 13 ). 
are lined with ECM molecules. Neural crest cells arise during 
neurulation and depart from the newly formed neural tube 
shortly after tube closure. The pathways followed by neural 
crest cells contain numerous matrix molecules including fi-
bronectin, hyaluronic acid, type I collagen, and probably 
various other molecules. In tissue culture, neural crest cells 
can migrate in a directed fashion along fibronectin rich mat-
rices (22) and can also migrate on laminin ( 17). When trans-
planted into premigratory regions of axolotl embryos, micro-
carrier filters coated with embryonic matrices from older 
embryonic regions can promote premature migration of 
neural crest cells ( 14 ). These studies indicate that the ECM 
may be both permissive and stimulatory for neural crest 
migration. 
The neural crest is an interesting model for examining the 
role of cell surface-ECM interactions because these cells 
migrate extensively during development along pathways that 
' Abbreviations used in this paper: CFSE, carboxyfluorescein diacetate 
succinimyl ester; ECM, extracellular matrix. 
610 
Recently, several monoclonal antibodies were described 
that recognize cell surface proteins involved in adhesion ( 11, 
16, 20). Two of these monoclonals, called JG22 and CSAT, 
perturb the adhesion of embryonic muscle cells to some 
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substrates in vitro. JG22 and CSAT apparently recognize the 
same antigen, a 140-kD complex of proteins localized in the 
region of cell-substratum attachment (6, 11, 16). The 140-
kD complex has recently been shown to co-distribute with 
both a-actinin and fibronectin, which suggests that the anti-
gens may represent a cell surface linkage between ECM mol-
ecules and the cytoskeleton (6). 
In this study I examined some effects of the monoclonal 
antibody JG22 on neural crest cells in vitro and in vivo. To 
test the effects of JG22 in vivo, a novel perturbation approach 
has been developed in which antibody-containing medium 
together with the hybridoma cells themselves are microin-
jected onto neural crest pathways. The hybridoma cells are 
labeled by a new fluorescent staining method that renders the 
cells identifiable in living preparations and histologically proc-
essed tissue sections. Both in tissue culture and in the embryo, 
JG22 affects the adhesion and migration of neural crest cells. 
In contrast, two other monoclonal antibodies, 1-B and 1-N, 
that bind to bands of the 140-kD complex precipitated by 
JG22, affect neither cell adhesion or neural crest migration. 
The results suggest that the adhesive interaction blocked by 
JG22 is important for normal neural crest migration. 
MA TE RIALS AND METHODS 
Neural Crest Cultures 
Primary cultures of neural crest cells were prepared from the neural tubes 
of Japanese quail embryos (corurnix coturnix japonica) (7, 8). Embryos were 
incubated for 48 h at 38°C, at which time their developmental age was 
comparable to chick stages 13-15 (12). The region of the trunk consisting of 
the six to nine most recently formed somites and some unsegmented mesen-
chyme was dissected away from the embryo. The neural tubes were isolated 
from surrounding tissues by proteolytic digestion with 150 U/ml ofcollagenase 
(CLS II; Cooper Biomedical Inc., Malvern, PA) for 15 min at 4°C and for an 
additional 6-9 minutes at 37'C. The reaction was stopped with complete tissue 
culture medium of Eagle's minimum essential medium containing 15% horse 
serum and 10% chick embryo extract, since the serum components contain 
endogenous protease inhibitors. The isolated neural tubes, with notochords 
sometimes attached to the ventral surface, were rinsed in complete medium 
and then plated onto fibronectin- or laminin-coated substrates. After 2-3 h, 
neural crest cells begin migrating away from the dorsal aspect of the neural 
tube and form a monolayer of cells on the culture dish. At this time, the 
cultures were fed complete medium (Eagle's minimum essential medium, 10% 
embryo extract, I 5% horse serum). In some cases, Eagle's minimum essential 
medium, a defined medium lacking serum and embryo extract, was substituted 
for complete medium during rinsing, plating. and feeding of the cells to 
eliminate any possible effects of serum or embryo extract components. Most 
cultures were used for adhesion assays 24 h after plating. In those cultures 
maintained for longer periods, neural tubes were scraped away after 24 h, 
leaving a monolayer of neural crest cells. Cultures were fed fresh medium every 
other day. For some experiments, somites isolated in the same manner as the 
neural tubes described above were plated onto fibronectin- or Jaminin-coated 
substrates. 
Attachment of Extracellular Matrix Molecules to 
Tissue Culture Plates 
To prepare fibronectin substrates, 35-mm petri plates were incubated with 
25 l'g/ml of fibronectin (Meloy Laboratories, Inc., Springfield, VA) in phos-
phate-buffered saline (PBS) for I 0 min. After removal of the fibronectin 
solution, the plates were air-dried. Laminin-coated dishes were prepared by 
incubating the petri dishes with 0.5 mg/ml poly-o-Jysine for 30 min at 37°C; 
the plates were washed four times with PBS and then incubated overnight with 
20 l'g/ml of laminin (kindly provided by Dr. L. Reichardt, University of 
California, San Francisco, CA). Before plating of neural tubes, the laminin 
solution was removed and the plates were washed with PBS. 
Hybridoma Cells 
JG22 hybridoma cells were kindly provided by Dr. David Gottlieb (Wash-
ington University. St. Louis. MO). 1-B and 1-N hybridoma cells were a generous 
gift from Dr. Clayton Buck (Wistar Institute, Philadelphia, PA). The cells were 
maintained in 75- or 250-ml tissue culture flasks in Dulbecco's modified eagle's 
medium containing 15% fetal bovine serum. 
Labeling of Hybridoma Cells 
Both 5- and 6-carboxyfluorescein diacetate succinimyl ester and fluorescein-
5-isothiocyanate diacetate (Molecular Probes Inc., Junction City, OR) were 
used to vitally dye cells. These dyes remain visible within the cells after fixation, 
paraffin embedding, and serial sectioning. Most experiments were performed 
with carboxyfluorescein diacetate succinimyl ester (CFSE) because this proved 
to be the more intense and Jong-lived marker. A IO mM stock solution of 
CFSE was prepared in dimethyl sulfoxide and stored at 4°C. For cell labeling, 
the CFSE working solution was prepared by diluting the stock solution I :300 
in PBS, pH 7.4. Hybridoma cells were centrifuged and the medium was 
removed. The cells were then suspended in CFSE working solution and incu-
bated at 37°C for 30 min. The labeled hybridoma cells were centrifuged, 
resuspended in medium containing antibodies, and microinjected into embryos. 
Concentration of Antibodies 
The culture medium was removed from the hybridoma cells and placed in 
Amicon microcentricon filters with a 30,000-mol-wt cut-off (Amicon Corp., 
Scientific Systems Div., Danvers, MA). The medium containing the mouse 
lgG's was centrifuged at 4,800 g for 2-3 h. This procedure yielded a 20-30 fold 
concentration of antibody in the retentate. 
Preparation of the Host 
White leghorn chicken embryos were incubated at 38°C. Embryos at devel-
opmental stages 8-10 were used for injections into the mesencephalic region, 
and those at stages 12-15 for injections in the trunk. The eggs were washed 
with 70% ethanol, windowed, and stained with an injection of India ink 
(Pelikan, Hanover, FRG) under the blastodisk (23). The vitelline membrane 
was removed over the injection site. After injection, the embryo was closed 
with adhesive tape and returned to the incubator until the time offixation. 
Microinjection of Antibody and Hybridoma Cells 
into Chick Embryos 
Microinjections were performed using a previously described injection tech-
nique (3, 4). The hybridoma cells and the antibody containing medium were 
backfilled into fine glass micropipettes. The tip of the pipette was broken off to 
produce an opening of 20-30-l'm diam. The injection micropipette was 
mounted on the electrode carrier of a micromanipulator and connected to an 
air pressure source. The manipulator was then used to insert the micropipette 
into the appropriate embryonic site, either lateral to the neural tube in the 
mesencephalon or into the embryonic somites in the trunk. The hybridoma 
cells and antibodies were expelled with a pulse of pressure and the injection 
needle was withdrawn. Approximately 4 nl was injected into the mesencephalic 
region, and -0.5 nl into the trunk somites. 
Histological Procedures 
PARAFFIN SECTIONS: Embryos were fixed for 2 h in Zenker's fixative 
and placed first into running water for 2 h, and then into 70% ethanol. The 
embryos were dehydrated, embedded in paraplast, and serially sectioned at IO 
I'm. Sections were mounted on albuminized slides and dried for several hours 
before antibody staining. 
CRYOSTAT s ECTIONS: Embryos were fixed in 4% paraforrnaldehyde in 
PBS (pH 7.4) for 1.5 h, rinsed in PBS, and dehydrated through a graded series 
of ethanols. Embryos were then placed in absolute ethanol for 48 h. In some 
cases, the paraformaldehyde fixation were omitted and embryos were placed 
directly into ethanol. The embryos were hydrated in PBS and placed first into 
5% sucrose containing 0.01 % azide for 2-4 hand then into 153 sucrose at 4°C 
overnight. They were placed in 7.5% gelatin/15% sucrose solution at 37°C for 
2-3 hours, oriented, and frozen in Tissue Tek OCT (Miles Laboratories Inc., 
Elkhart, IN) in liquid nitrogen. Frozen sections were cut at IO I'm on an A/0 
Histostat Cryostat (Reichardt Scientific Instruments, Buffalo, NY). 
lmmunofluorescent Staining 
Slides were scanned for fluorescently labeled hydridoma cells which are 
readily visible under epifluorescent illumination within paraffin sections. The 
sections containing hybridoma cells and neighboring sections were then stained 
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with a monoclonal antibody HNK-1 that recognizes neural crest cells. HNK-1 
is a mouse lgM that stains migrating avian neural crest cells, as well as neurons, 
glia, and a subpopulation ofleukocytes (26). The cell surface antigen recognized 
by HNK-1 is the same antigen recognized by NC-! (26). The sections were 
deparaffinized in histosol, taken through a graded series of alcohols, and placed 
into PBS. They were then incubated with HNK-1(diluted1:30) in a humidified 
chamber at room temperature overnight. The slides were washed in PBS and 
incubated with a rabbit antibody against mouse lgM's for 1 hat room temper-
ature. The sections were then washed and incubated with a fluorescein-conju-
gated goat antibody against rabbit IgG's. After sections were rinsed in PBS, a 
few drops of fresh PBS were added; the slides were covered with coverslips and 
observed under a Zeiss epifluorescence microscope. 
Because JG22 is an lgG whereas HNK-1 is an IgM, it is possible to perform 
double labeling experiments using differently labeled second antibodies. Cryo-
stat sections of chick embryos were prepared. Sections were incubated overnight 
in a humified chamber with medium containing JG22 and with HNK-1 {1:30). 
The sections were washed in PBS, incubated with a rabbit anti-mouse lgM for 
1 h, washed, and stained with rhodamine-conjugated goat antibodies against 
mouse lgG (I :25) and fluorescein-conjugated goat antibodies against rabbit 
IgG's. After they were rinsed and covered with coverslips, sections were observed 
under epifluorescent illumination. Data were recorded photographically and 
on videotapes using a Silicon Intensified Target (SIT; RCA, Lancaster, PA) 
image intensifying video camera and a video recorder. 
Quantitative Analysis of Neural Crest Inhibition 
To quantitate the volume occupied by neural crest cells, serial sections 
through the injected embryos were examined under the fluorescence micro-
scope. Those areas containing neural crest cells could be recognized by their 
HNK-1 fluorescence. The main site of injection was easily identifiable since it 
contained the highest concentration of hybridoma cells. Videotape recordings 
were made of sections throughout the mesencephalon anterior and posterior to 
the injection site, or through one or more somites anterior and posterior to the 
injection site in the trunk. To quantitate the effects of JG22 on neural crest 
migration, tracings that outlined the area occupied by neural crest cells were 
prepared off of the video screen for every section along -220 µm of the 
anterior-posterior extent of the embryo centered on the injection site. The 
surface area of each tracing was determined using an Orthoplex Coordinate 
Sensor Type 3825-1 (Elographics Inc., Oakridge, TN) and a Wang series 600 
computer (Wang Laboratories, Inc., Lowell, MA). For each side of the embryo, 
the surface areas from all tracings were summed. Because the volume equals 
the surface area times the section thickness, the ratio of the summed areas 
reflects the fraction of the volume occupied by neural crest cells on the injected 
versus the control side. 
RESULTS 
JG22 is an antibody made against chick skeletal muscle cells 
( 11) that recognizes a cell surface molecule involved in muscle 
cell attachment to tissue culture substrates. In the presence of 
the antibody, muscle cells undergo rapid changes in mor-
phology and sometimes detach from the substrate, whereas 
fibroblasts in the same cultures remain unaffected. The effects 
of JG22 on neural crest adhesion in vitro and neural crest 
migration in vivo are described below. 
Effects of JC22 Antibody on Neural Crest 
Cells In Vitro 
Neural crest cell cultures were prepared from quail neural 
primordia as described (see Materials and Methods) and 
plated onto fibronectin or laminin-coated petri dishes. The 
culture medium was removed and replaced with medium 
conditioned by JG22 hybridoma cells. Control cultures were 
fed either medium alone (Dulbecco's modified Eagle's me-
dium plus 15% fetal bovine serum) or medium containing 
the 1-B or 1-N control antibodies. The control antibodies 
bind to bands I and 3, respectively, in the 140-kD complex 
recognized by JG22 and CSA T (Buck, C., personal commu-
nication). Neural crest cells are typically grown in a rich 
culture medium containing horse serum and embryo extract. 
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For some experiments, neural crest cells were plated and 
grown in medium without serum or embryo extract to elim-
inate any possible contributions of horse serum or embryo 
extract components to the tissue culture substrate. Identical 
results were observed in both types of media. 
JG22 antibodies caused rapid and profound changes in the 
morphology of neural crest cells grown on fibronectin or 
laminin substrates. In neural crest cultures 24 h after plating, 
most neural crest cells rounded up and became phase bright 
within minutes after addition of the antibody (Fig. I). Some 
of the rounded cells detached from the dish, whereas others 
remained tenuously attached. In addition, many neural crest 
cells tended to form small aggregates. Similar effects were 
observed in cultures of various ages ranging from 6 h to 8 d 
after plating. In contrast, other cell types such as neural tube 
cells, notochord cells, or somite cells included on the same 
culture dish underwent little or no morphological change. In 
some cases, the edges of the epithelial sheets formed by the 
cultured neural tube cells did appear to roll up slightly. Cells 
in control cultures fed fresh culture medium, medium con-
taining 1-B, or medium containing 1-N antibodies were un-
perturbed. 
JC22 Antigen Is Present on Migrating 
Neural Crest Cells 
Cryostat sections of chicken embryos were double labeled 
with JG22 antibody (a mouse IgG) and with HNK-1 antibody 
(a mouse IgM). HNK-1 was used to identify neural crest cells 
(26). JG22 antigen was detected on the surface of migrating 
neural crest cells, in both the trunk and the mesencephalic 
region (Fig. 2). In addition, JG22 staining was present around 
the basal surface of the neural tube, notochord, and myotome. 
A detailed description of the distribution pattern of the JG22 
antigen in early embryos will be described elsewhere (Kroto-
ski, D., E. Montgomery, and M. Bronner-Fraser, manuscript 
in preparation). It is interesting that JG22 antibody did not 
cause detachment of neural tube, notochord, or somite cells 
from fibronectin or laminin substrates in vitro. These results 
suggest that these tissues may have some adhesive mecha-
nisms in addition to the antigen recognized by JG22. 
Labeling of JC22 Hybridoma Cells 
The purpose of injecting hybridoma cells into the devel-
oping embryos was twofold: to serve as a convenient marker 
for the site of injection and to provide a continuous source of 
antibody within the embryo. To allow the cells to be located 
after injection, the hybridomas must be labeled with a marker 
that can survive the fixation and embedding procedure used 
to analyze the data. In addition, the dye must be nondeleter-
ious to the function of the hybridoma cells. Of the dyes tested, 
CFSE was found to stain the hybridoma cells intensely both 
before and after fixation in I 0% buffered formalin or in 
Zenker's fixative. The CFSE diffuses freely across the cell 
membrane, where intracellular esterases release the chroma-
phore. The negatively charged chromaphore is then retained 
within the cell. The CFSE remains within the labeled cells 
over Jong periods; one set of hybridoma cells was maintained 
in culture for 3 wk and still contained many fluorescent cells. 
To assess the effects of CFSE labeling on antibody produc-
tion, hybridoma cells were labeled as described in Materials 
and Methods, placed in fresh culture medium, and allowed 
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F1GURE 1 Phase-contrast photomicrographs illustrating the effects of JG22 antibody on neural crest cells in vitro. (a) A culture 
of neural crest cells grown on fibronectin 24 h after explantation of the neural tube (nt) onto the culture dish. The neural crest 
cells have emigrated from the neural tube and have formed a monolayer on the substrate. (b) The same field 15 min after 
addition of JG22 antibodies. Many cells have become rounded and phase bright, and often detach from the substrate; other cells 
form small aggregates. (c) The same field after 60 min. More cells have detached or formed aggregates. Note that the neural 
tube does not appear to be affected. x 200. 
F1GURE 2 Fluorescence photomicrographs of a cryostat section 
through the trunk of a 2.5-d chick embryo. (a) Rhodamine immu-
nofluorescence of JG22 staining. x 880. The JG22 antigen is seen 
on the basolateral side of the neural tube (nt), the myotome (m), 
and on the surface of neural crest cells (nc). In addition, JG22 is 
detected around the notochord (not shown). (b) The same section 
visualized through a fluorescein filter set shows HNK-1 staining of 
neural crest cells x 880. 
to proliferate for 24 h. The culture medium was then removed 
and tested for the presence of JG22 antibodies by an assay of 
its effects on neural crest adhesion in vitro. The culture 
supernatant from the labeled cells caused rapid rounding and 
detachment of neural crest cells; these effects were identical 
in morph0logy and time course to those caused by JG22 
medium removed from unlabeled hybridoma cells. 
Effects of JC22 Antibody on Cranial 
Neural Crest Migration 
After they were labeled, hybridoma cells were resuspended 
in either fresh medium or medium that contained JG22 
antibody concentrated 20- to 30-fold. The antibody and cell 
suspension was backfilled into a micropipette and injected 
into the mesencephalon during the early stages of cranial 
neural crest migration. Each embryo was injected lateral to 
the mesencephalic neural tube with -4 nl cell suspension. 
The embryos were allowed to develop from 4 to 22 h after 
injection, fixed, sectioned, and stained with HNK-1 antibody 
to monitor the effects of the injection on neural crest migra-
tion. The labeled hybridoma cells were easily detected in fixed 
and antibody-stained sections because the cells have round, 
brightly fluorescent cell bodies, which can be visualized with 
several different fluorescent filter sets. 
In an initial series of experiments, the effects of the JG22 
hybridoma cells alone were examined; 10 embryos were in-
jected with JG22 hybridoma cells plus fresh culture medium, 
without JG22 antibody. In one of these embryos, a reduction 
of neural crest migration was observed on the injected side 
relative to the control side. In the remaining embryos, few or 
no differences in cell numbers were noted between injected 
and control sides; however, a cell free zone was observed 
between the hybridoma cells and the neural crest cells. In the 
case of JG22 hybridoma cells, 78 ± 6% (n = 6 embryos) of 
the hybridoma cells were located at least one cell diameter 
away from the closest neural crest cell. This is significantly 
higher (P < 0.025) than in control embryos, where only 31 ± 
7% (n = 3 embryos injected with 1-B hybridoma cells) and 
41 ± 25 (n = 5 embryos injected with 1-N hybridoma cells) 
were one or more cell diameters distant from the nearest 
neural crest cell. These results suggest that the JG22 hy-
bridoma cells usually affect neural crest cells only at a local 
level, within a few cell diameters. 
In a second series of experiments, hybridoma cells were 
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FIGURE 3 Fluorescence photomicrographs of embryos fixed 11 h 
after injection of JG22 antibodies and hybridoma cells into the 
mesencephalon. The sections were stained with HNK-1 antibodies 
to recognize neural crest cells. Neural crest cells in the mesenceph-
alon normally emigrate away from the neural tube (nt) and into the 
mesenchyme just beneath the ectoderm. (a) A section through the 
main injection site, containing the highest concentration of hy-
bridoma cells. x 330. The brightly fluorescent hybridoma cells that 
were labeled with CFSE before injection are easily seen on the 
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injected together with antibody-containing medium. In addi-
tion to the cell-free space observed between most injected 
JG22 hybridoma cells and the endogenous neural crest cells, 
profound alterations in neural crest migration were observed 
in 34 of the 41 embryos injected with JG22 antibodies (Fig. 
3), The amount of neural crest migration on the injected side 
appeared reduced. The neural crest cell volume was deter-
mined by measuring the area occupied by neural crest cells 
in each section through the mesencephalon in six randomly 
selected embryos, The volume on the injected side was re-
duced by 54 ± 5% in these animals relative to the noninjected 
side. Note that the calculated 54%reduction is summed over 
the entire mesencephalon and that individual sections may 
have a much larger difference in neural crest cell number 
between the injected and control side (Fig. 3b). The decrease 
in volume on the injected side probably reflects an actual 
decrease in numbers of neural crest cells; on both injected 
and control sides, neural crest cells migrate in close association 
to one another and the size of individual cells appears un-
changed on the injected side. 
In addition to reduced cell numbers, 9 of the 34 affected 
embryos had a lobule containing HNK-1 positive cells pro-
truding into the lumen of the neural tube (Fig. 3c). Presum-
ably, these stained cells are neural crest cells; HNK-1 normally 
recognizes neural crest cells only after they have departed 
from the neural tube. This build-up of neural crest cells may 
reflect some inhibition of normal crest emigration from the 
dorsal neural tube. It is interesting that the most profound 
alterations in neural crest migration were often observed 
posterior to the main injection site (i.e., the region with the 
highest concentration of hybridoma cells). In the anterior 
regions, many neural crest cells may have already left the 
neural tube at the time of injection. Perhaps the more caudal 
regions of the mesencephalon, where neural crest migration 
is just beginning, have the greatest sensitivity to the injected 
antibody. 
In a few of the experimental embryos, those neural crest 
cells present on the injected side migrated along an aberrant 
pathway; instead of moving laterally under the ectoderm the 
cells migrated along the ventral portion of the neural tube 
and through the mesenchyme. In 7 of the 41 embryos, no 
alterations in neural crest migration were apparent. In these 
cases, it is possible that the antibody was diluted through 
leakage out of the puncture hole made by the injection needle. 
Effects of 1-8 and 1-N Antibodies on Cranial 
Neural Crest Migration 
A possible complication of the antibody injection approach 
right-hand side (indicated by the arrow). In the presence of JG22 
antibodies, the number of neural crest cells on the injected side 
was markedly reduced. Quantitative reconstruction of serial sec-
tions throughout the mesencephalon of this particular embryo 
demonstrated a 51 % reduction in neural crest cell volume on the 
injected side relative to the control side. (b) Another section 
through the posterior mesencephalon of the same embryo illus-
trated in a. x 330. The reduction in neural crest cell number is 
more severe and the cells have not migrated as far ventrally on the 
injected side. In addition, a lobule has formed within the neural 
tube (nt) which contains neural crest cells (identified by HNK-1 
staining). (c) Another embryo at higher magnification with a pro-
found build up of neural crest cells (nc) in the lumen of the 
mesencephalic neural tube. x 1,200. 
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for perturbing neural crest migration is that the effect pro-
duced by an antibody may be unrelated to a functional block 
of the antigen it recognizes. To control for such a possibility, 
the experiments described above were repeated using two 
different hybridomas clones, 1-B or 1-N, instead of JG22. 1-
B and 1-N cells produce antibodies that recognize bands 1 
and 3, respectively, of the complex precipitated by JG22 and 
CSA T (Buck, C., personal communication), but unlike JG22 
and CSA T do not alter cell adhesion. In tissue culture, neither 
1-B or 1-N antibodies caused detachment of neural crest cells. 
After the injection of 1-B (n = 14 embryos) or 1-N (n = 8 
embryos) hybridoma cells and concentrated antibody solution 
into the mesencephalic region, no inhibition of neural crest 
migration and no build-up of neural crest cells within the 
dorsal neural tube was observed (Fig. 4 ). The volume occupied 
by neural crest cells on both the injected and control sides 
was quantitated in serial sections through six representative 
embryos. The volume on the side injected with hybridoma 
cells was 102 ± 83 of that on the control side for 1-B, and 
98 ± 7% for the 1-N antibody. The reduction for embryos 
injected with JG22 hybridoma cells was 54%. Thus, introduc-
tion of IgG's and hybridoma cells that do not block the 
function of the 140-kD complex had no noticeable effect on 
the distribution of neural crest cells. These results suggest that 
the alterations in neural crest migration caused by JG22 result 
from a functional block of the 140-kD complex. 
Effects of JC22 Antibody on Trunk 
Neural Crest Migration 
To examine the affects of JG22 antibody on neural crest 
migration in the trunk, JG22 antibodies and labeled hy-
bridoma cells were injected into the trunk somites. Injections 
were made -10 somites anterior to the most recently formed 
somite. This is a level where endogenous neural crest cells are 
just beginning to penetrate the anterior part of the somite 
after the somite dissociates into the dermatome, myotome, 
and sclerotome (Rickmann, R., J. Fawcett, and R. Keynes, 
manuscript in preparation; Bronner-Fraser, M., manuscript 
submitted for publication). Approximately 0.5 nl was injected 
into each somite. Embryos were fixed and processed from 7 
to 21 h after the initial injection. 
As observed in the cranial region, a separation between 
injected JG22 hybridoma cells and neural crest cells was 
observed in the trunk. Other effects of JG22 on trunk neural 
crest migration were variable. Seven of the 28 embryos ex-
amined did have a decreased volume of neural crest cells on 
the injected side, though to a lesser extent than noted in the 
mesencephalon. A 153 reduction in neural crest cell volume 
on the injected side relative to the control side was determined 
by quantitative reconstruction of one representative embryo. 
In another two embryos, neural crest cells were observed 
migrating along aberrant pathways. In these cases, crest cells 
were seen invading the region around the notochord, or were 
seen within the myotome. In normal embryos, neural crest 
cells avoid the space around the notochord and do not pene-
trate the myotome ( 1.9). In 19 of the 28 embryos examined, 
no marked differences in neural crest migration were observed 
on the injected side relative to the control side. 
DISCUSSION 
This study examines the effects of the JG22 antibody on 
neural crest cell adhesion in tissue culture and in the embryo. 
F1GURE 4 Fluorescence photomicrographs of a control embryo 
fixed 11 h after injection of 1-N hybridoma cells and antibodies 
into the mesencephalon. The sections were stained with HNK-1 
antibodies to recognize neural crest cells. (a) A section through the 
main injection site containing the highest concentration of hy-
bridoma cells, indicated by the arrow. x 260. (b) Another section 
through the posterior mesencephalon of the same embryo illus-
trated in a. x 260. After injection of control hydridoma cells and 
antibodies, no differences in the number of neural crest cells were 
noted between the injected side and the control side. Quantitative 
reconstruction of serial sections throughout the mesencephalon of 
this particular embryo demonstrated that the neural crest cell 
volume on the injected side was 96% of that on the control side. 
In contrast, embryos injected with JG22 antibodies and hybridoma 
cells had a 50% reduction in neural crest cell volume (compare Fig. 
3). nt, neural tube. 
The antibody, originally found to perturb adhesion of skeletal 
muscle cells in vitro ( 11 ), was discovered to cause rounding 
and detachment of neural crest cells plated on both fibronectin 
and laminin tissue culture substrates. Control antibodies ( 1-
B and 1-N) that bind to bands of the 140-kD complex 
precipitated by JG22 (Buck, C., personal communication) 
had no affect on neural crest cell adhesion. In frozen sections 
of young chick embryos, the JG22 antigen is present on the 
surface of neural crest cells and is also found on the basal 
surface of the neural tube, myotome, and notochord. The 
latter tissues, however, were not affected in vitro by the 
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addition of JG22 antibodies. 
To examine the effects of this antibody on neural crest cells 
in vivo, a new approach for perturbing embryonic cell migra-
tion was developed. JG22 antibodies together with the hy-
bridoma cells were microinjected onto neural crest pathways. 
The hybridoma cells were stained with a long-lasting fluores-
cent marker that is nondeleterious and has the advantage of 
being detectable in fixed histological sections. The labeled 
hybridoma cells serve both as markers for the exact locus of 
the injection site and as a continuous source of antibody. 
When JG22 antibodies and hybridoma cells were microin-
jected into the mesencephalic neural crest pathway, the fol-
lowing changes were observed: (a) neural crest migration was 
reduced in 833 of the injected embryos; (b) a build-up of 
neural crest cells within the lumen of the neural tube occured 
in 263 of the affected embryos; (c) neural crest cells migrated 
along aberrant pathways in 63 of the affected embyros; and 
(d) a space of one or more cell diameters was seen between 
the neural crest cells and most of the JG22 hybridoma cells 
in all injected embryos. Control injections performed with 
the 1-B or 1-N antibodies and hybridoma cells did not cause 
alterations in neural crest migration. These findings suggest 
that the observed effects are caused by functional block of the 
140-kD complex recognized by JG22. In the the trunk region, 
the effects of JG22 were far less reproducible and consistent 
for the antibody titer and injected volumes used in this study. 
In a few cases, the numbers of neural crest cells were some-
what reduced, and in other cases, the crest cells moved in 
aberrant directions to invade the perinotochordal space and 
the myotome. Normally, no crest cells are seen within these 
spaces (Bronner-Fraser, M., manuscript submitted for publi-
cation; 19). 
A quantitation of neural crest cell volume of the injected 
side relative to the noninjected side of the embryos demon-
strated a 503 reduction of cranial neural crest cell migration 
after injection of JG22 antibodies; no reduction was observed 
in control embryos injected with 1-B or 1-N antibodies and 
hybridoma cells. The serial reconstructions used in this study 
demonstrate that simple quantitation can provide useful in-
formation in systems as complicated as neural crest migration. 
Such methods provide a global picture of the effects produced 
by perturbation techniques. In contrast, examination of in-
dividual sections may prove misleading since no section can 
be truly representative and the effects may be masked or 
amplified by the exact plane of section. 
Several possible explanations may account for the apparent 
reduction in the number of neural crest cells after injection 
of JG22. For example, the antibody may diminish the ability 
of neural crest cells to emigrate from the neural tube. In the 
absence of compensatory hyperplasia, this would result in a 
decrease in the total number of neural crest cells on the 
injected side. In support of this idea, JG22 often led to a 
build-up of neural crest cells within the lumen of the neural 
tube. Alternatively, JG22 may affect the neural crest cells 
only after their departure from the neural tube, by altering 
either their ability to proliferate or their survival. Future 
experiments that examine the effects of JG22 on neural crest 
cells in vitro may distinguish among these alternatives. 
The results indicate that the cell surface antigen recognized 
by JG22 is important for the normal migration of neural crest 
cells in the cranial region since the amount of neural crest 
migration is reduced in the presence of the antibody. Neural 
crest migratory routes in the mesencephalon are rich in fibro-
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nectin (IO). Therefore, it is likely that JG22 perturbs the 
normal adhesion of neural crest cells to a fibronectin-rich 
matrix and that this adhesion is important for normal cell 
migration. It is interesting that a similar inhibition of neural 
crest migration was observed by Boucaut et al. (2) after a 
synthetic decapeptide that appears to contain the cell recog-
nition sequence of fibronectin (21, 27) was injected into the 
mesencephalic neural crest pathway. These investigators ob-
served a bilateral reduction in numbers of cranial neural crest 
cells and a build-up of neural crest cells within the lumen of 
the neural tube (2). Presumably, both the decapeptide and 
the JG22 antibody alter the adhesion of neural crest cells to 
fibronectin. Support for this idea comes from a recent study 
on chick embryo fibroblasts, which demonstrates that the 
JG22 antigen co-distributes with extracellular fibronectin and 
intracellular a-actinin ( 6). It is surprising that JG22 also affects 
adhesion of neural crest cells to laminin-coated substrates, 
which suggests that the 140-kD complex may not be com-
pletely specific for fibronectin. Studies that show that the 
JG22 antigen is present on the basolateral membrane surface 
of the intestinal epithelium (5) suggest that the 140-kD com-
plex may be associated with laminin in situ. In contrast to 
JG22, the synthetic peptides containing the fibronectin cell 
recognition site do not appear to affect cell adhesion to 
laminin substrates. 
Fibronectin is present in both the trunk and cranial regions 
of the embryo during neural crest migration (JO, 24). At the 
concentrations used in this study, the effects of JG22 antibody 
in the trunk were less dramatic than those observed in the 
cranial region, even though the antibody and hybridoma cells 
were injected into regions of active neural crest migration. 
This may result from the fact that a much smaller volume of 
antibody can be conveniently introduced into the trunk com-
pared to the cranial regions. The smaller volume occupied by 
neural crest cells in the trunk might be expected to partially 
compensate for the smaller injection volume; however, the 
results show that the trunk injections are less effective. Perhaps 
the smaller injected volume leads to a greater proportional 
leakage of antibody out of the injection site, thereby lowering 
the effective antibody concentrations. In addition, the tissues 
surrounding the injection site may absorb more JG22 anti-
body in the trunk than in the cranial region leaving less 
antibody free to interact with the neural crest cells. Another 
possible and more intriguing explanation is that the extracel-
lular matrix may be different or more complex in the trunk 
than in cranial regions. Though neural crest cells in the 
mesencephalon seem to follow fibronectin-rich pathways, re-
cent studies indicate that most neural crest cells in the trunk 
migrate through the anterior portion of each somite, which 
contains little or no fibronectin (Rickmann, R., J. Fawcett, 
and R. Keynes, manuscript in preparation). If neural crest 
cells migrate along ECMs, additional species of matrix mole-
cules must be present in the trunk. Thus, the adhesive inter-
actions perturbed by JG22 may not be the dominant cell 
surface-ECM interaction involved in trunk neural crest mi-
gration. We are currently examining these different possibili-
ties. 
It is interesting to note that a number of embryonic cell 
types including the neural tube, notochord, and myotome 
have the JG22 antigen on their surface; however, the adhesion 
of these cells to tissue culture substrates is not perturbed in 
the presence of antibody. Decker et al. (9) have reported 
similar findings using the CSA T antibody. They detected the 
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140-kD complex on the surface of skeletal and cardiac muscle 
as well as on tendon, skeletal, dermal, and cardiac fibroblasts. 
In contrast, the antibody caused detectable morphological 
changes only on skeletal muscle and cardiac fibroblasts. They 
suggest that there may be an adhesive hierarchy in different 
cell types with the CSAT/JG22 antigen appearing as the 
lowest common denominator. This idea receives support from 
the finding that JG22 antibody prevents the initial adhesion 
of chick embryo fibroblasts to fibronectin substrates (6) but 
does not affect cell morphology when added after cell attach-
ment and spreading have taken place. 
The present study describes a new antibody perturbation 
technique in which both the antibody and hybridoma cells 
are introduced into embryos. This perturbation approach may 
be generally applicable in studies elucidating the roles of 
certain antigens in early embryogenesis. In this article a novel 
cell labeling technique is also described which allows long-
term identification of implanted cells. This labeling method 
may provide a generally useful marker for intra- and interspe-
cific grafts (Bronner-Fraser, M., and S. Fraser, manuscript in 
preparation), as well as for in vitro experiments in which 
differentially labeled tissues are brought into contact. By use 
of this approach, the antibody JG22 was found to cause 
profound alterations in cranial neural crest migration. This 
probably results from the binding and functional inactivation 
by JG22 of a cell surface complex involved in recognition of 
fibronectin (6). The results suggest that this cell surface mol-
ecule may be important for normal cranial neural crest mi-
gration. The results on neural crest migration are too incom-
plete to support the naive suggestion that interactions between 
a single cell surface component and an ECM molecule are 
uniquely responsible for the guidance of a complex develop-
mental process such as neural crest migration. Rather, the 
data remain consistent with the presence of a number of 
molecules; these may function synergistically such that per-
turbation of one or more of their interactions would alter 
normal morphogenesis. 
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Note Added in Proof Since this manuscript went to press, analogous 
experiments were performed using CSA T ( 16; kindly provided by Dr. 
C. Buck), which binds to the same 140-kD complex recognized by 
JG22. The preliminary results suggest that CSAT causes alterations 
in neural crest adhesion in vitro and migration in vivo similar to 
those observed after exposure to JG22. 
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